Altshuler Shaham LTD Nevro Corp Transaction History

Altshuler Shaham LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$132.81 - $182.18 $29,749 - $40,808	-224 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $30,950 - $41,292	224 New	224 $39,000
Q3 2020 Nov 10, 2020	SELL	$114.09 - $145.51 $17,912 - $22,845	-157 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$89.45 - $129.85 $6,261 - $9,089	-70 Reduced 30.84%	157 $19,000
Q1 2020 May 12, 2020	SELL	$70.23 - $144.31 $3,441 - $7,071	-49 Reduced 17.75%	227 $23,000
Q4 2019 Feb 11, 2020	BUY	$76.41 - $117.54 $12,607 - $19,394	165 Added 148.65%	276 $32,000
Q3 2019 Nov 12, 2019	BUY	$61.52 - $91.1 $6,828 - $10,112	111 New	111 $9,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.